Simple N(ε)-thioacetyl-lysine-containing cyclic peptides exhibiting highly potent sirtuin inhibition
- PMID: 26874402
- DOI: 10.1016/j.bmcl.2016.01.086
Simple N(ε)-thioacetyl-lysine-containing cyclic peptides exhibiting highly potent sirtuin inhibition
Abstract
Transforming a linear pentapeptidic pan-SIRT1/2/3 inhibitor harboring the catalytic mechanism-based sirtuin inhibitory warhead N(ε)-thioacetyl-lysine into its side chain-to-side chain cyclized derivatives was able to furnish highly potent SIRT1/2/3 inhibition (low nM). This finding attests to the feasibility of developing structurally simple yet highly potent catalytic mechanism-based cyclic peptidic sirtuin inhibitors.
Keywords: Catalytic mechanism-based; Cyclic peptide; Inhibitor; Sirtuin.
Copyright © 2016 Elsevier Ltd. All rights reserved.
Similar articles
-
Cyclic peptide-based potent and selective SIRT1/2 dual inhibitors harboring Nε-thioacetyl-lysine.Bioorg Med Chem Lett. 2016 Nov 1;26(21):5234-5239. doi: 10.1016/j.bmcl.2016.09.055. Epub 2016 Sep 22. Bioorg Med Chem Lett. 2016. PMID: 27707605
-
A mechanism-based potent sirtuin inhibitor containing Nε-thiocarbamoyl-lysine (TuAcK).Bioorg Med Chem Lett. 2011 Aug 15;21(16):4753-7. doi: 10.1016/j.bmcl.2011.06.069. Epub 2011 Jun 22. Bioorg Med Chem Lett. 2011. PMID: 21752644 Free PMC article.
-
A bicyclic pentapeptide-based highly potent and selective pan-SIRT1/2/3 inhibitor harboring Nε-thioacetyl-lysine.Bioorg Med Chem. 2020 Apr 1;28(7):115356. doi: 10.1016/j.bmc.2020.115356. Epub 2020 Feb 5. Bioorg Med Chem. 2020. PMID: 32067892
-
Sirtuin Inhibition: Strategies, Inhibitors, and Therapeutic Potential.Trends Pharmacol Sci. 2017 May;38(5):459-472. doi: 10.1016/j.tips.2017.01.009. Epub 2017 Apr 5. Trends Pharmacol Sci. 2017. PMID: 28389129 Review.
-
Sirtuin mechanism and inhibition: explored with N(ε)-acetyl-lysine analogs.Mol Biosyst. 2011 Jan;7(1):16-28. doi: 10.1039/c0mb00033g. Epub 2010 Sep 15. Mol Biosyst. 2011. PMID: 20842312 Review.
Cited by
-
Thienopyrimidinone Based Sirtuin-2 (SIRT2)-Selective Inhibitors Bind in the Ligand Induced Selectivity Pocket.J Med Chem. 2017 Mar 9;60(5):1928-1945. doi: 10.1021/acs.jmedchem.6b01690. Epub 2017 Feb 15. J Med Chem. 2017. PMID: 28135086 Free PMC article.
-
A Selective Cyclic Peptidic Human SIRT5 Inhibitor.Molecules. 2016 Sep 10;21(9):1217. doi: 10.3390/molecules21091217. Molecules. 2016. PMID: 27626398 Free PMC article.
-
Cyclic Peptide-Based Sirtuin Substrates.Molecules. 2019 Jan 24;24(3):424. doi: 10.3390/molecules24030424. Molecules. 2019. PMID: 30682801 Free PMC article.
-
Insights on the Modulation of SIRT5 Activity: A Challenging Balance.Molecules. 2022 Jul 12;27(14):4449. doi: 10.3390/molecules27144449. Molecules. 2022. PMID: 35889322 Free PMC article. Review.
-
Current Trends in Sirtuin Activator and Inhibitor Development.Molecules. 2024 Mar 6;29(5):1185. doi: 10.3390/molecules29051185. Molecules. 2024. PMID: 38474697 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information